Medical Care Technologies Inc (ID) (MDCE)

Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

Company discusses secure image handling, privacy-focused platform architecture, and future compliance-oriented development initiatives

MESA, AZ / ACCESS Newswire / June 16, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today provided an update on the privacy-focused architecture being incorporated into its MDCE Melanoma Scan Beta platform.

The MDCE Melanoma Scan Beta platform is being developed as an AI-assisted imaging and skin wellness pre-screening technology designed to support skin health through visual monitoring workflows, and preventative wellness awareness initiatives. As development progresses, the Company continues to prioritize secure image handling, user authentication, access management controls, and privacy-focused platform design.

Additional information regarding the MDCE Melanoma Scan Beta platform can be found at https://medicalcaretechnologies.com/.

Medical Care Technologies believes privacy, security, and responsible data stewardship are essential components of next-generation healthcare and wellness technologies. Current development initiatives include evaluating secure image management workflows, data governance practices, and software architecture designed to support long-term platform scalability and future compliance considerations.

"Building trust begins with building the right foundation," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "As we continue developing the MDCE Melanoma Scan Beta platform, we are focused on creating a secure, scalable, and professionally engineered AI imaging platform designed around privacy, security, and responsible software development practices."

The Company believes that establishing privacy-focused infrastructure early in the development lifecycle may help support future platform growth, user confidence, and operational maturity as the platform continues through testing and refinement.

Medical Care Technologies views the MDCE Melanoma Scan Beta platform as an important component of its broader AI imaging strategy and long-term vision involving artificial intelligence, computer vision technologies, preventative wellness applications, and scalable software platforms.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK: MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and advanced software development initiatives. The Company is actively developing AI-assisted imaging and computer vision technologies designed to support emerging opportunities across digital health and preventative wellness markets.

Contact Information

Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding product development, testing activities, future platform capabilities, commercialization opportunities, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1178043

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

Most the long-term investors Marshall tanked the share price on. At the exact same time claiming his concern, care, and support for his company’s shareholders.

Marshall seems oblivious to the yarn ball theory of economics (lol); pulling the string on one end he knows nothing until after the fact that it screws with and makes deficient the neat n tidy other side of the same yarn ball.

“… because nobody wants to buy into something that is going to be diluted.”

Somehow that’s the company having “turned the corner,” so saith the ‘only positives’.

“Marshall needs to stabilize the company's stock trading. JMO.”

This has been the situation for years now. And now, the stock for retail can’t get any lower.

He just has to produce a solid product.

PRs about minute details don’t acheive it.

Or keep having more auctions, selling more items.
Marshall has completely abandoned expanding auction services. Remember when he promoted “infinite” in Infinite Auctions as ‘all kinds of auction items’ were going to be sold. When new alignments with bigger to big name auction houses was coming. When Real Game Used (RGU) was going to be licensed out because RGU authentication was such a game changer?
Before that, NFTs was the direction of the company.

Then later he went for cheap Reg-A money selling 46% of the company to one man, for cash he ran out of quickly.
Which looks like insider trading.
Company too small for SEC to care about.

Now, last we heard from Marshall, he intends to do it again with the same buyer. But the ‘26 First Quarterly came out (with far out claims of no acquired Reg-A shares having been re-sold, countering a previous year’s Q3 filing). So blatant, it suggests, if he has any sense, that he may now change his initial second Reg-A plans (my reasoning, that generally surprises when Marshall does the opposite).

So, no one is buying.

notice we hear jackie squat about the AI recipe app now that it’s actually been released.

All that PR after PR after PR hype.

The Dec. 2025 demand that we get our popcorn out for the impending MDCE price rocket ship after Marshall’s press release after press release barrage.

Marshall was certain he’d created a tremendous pump that was going to fly.

Turns out, he actually has to produce something.

But, I like his tenacity. And his optimism.

Maybe he’ll figure out another approach than pulling the yarn ball thread that is the same tidy thread on the other side undone by he pulling of the thread.

Kaplan ‘owns’ a lot of shares that he no longer has, yet he has them… the latest filing says so. Wait, which does it say?

Marshall requires professional legal and filing assistance to get it right, past and moving forward.

imo

He’s a one man operation. (Where’s the Arizona University news update?)

Hope he hits his target, because I expect if so it will be legit. Thing is, he keeps moving his target too.

Wow. This Vol is staggering!

Marshall is making progress with this company as demonstrated by today's PR, but it's not going to be a quick success. He has to get the stock structure of the company finalized so people know what they are buying. Keeping the Reg A on the table may help him raise funds, but it's killing the trading as we have been seeing because nobody wants to buy into something that is going to be diluted. Unfortunately, the Pinks aren't where your long-term investors are and the long-term investor is what Marshall needs to stabilize the company's stock trading. JMO

Kobe Bryant's Series-Clinching NBA Finals Sneakers Could Become One of the Most Watched Sports Memorabilia Auctions of the Year

Photo-Matched and Dual-Signed Adidas "The Kobe 1" Sneakers from the Lakers' 2001 NBA Championship Victory Open at $10,000 with a $240,000 Buy-It-Now Option

MESA, AZ / ACCESS Newswire / June 15, 2026 / Infinite Auctions is a wholly owned subsidiary of Medical Care Technologies, Inc. (OTC PINK:MDCE) has announced the upcoming offering of one of the most significant Kobe Bryant game-worn artifacts to reach the public marketplace in recent years: Kobe Bryant's game-worn and dual-signed Adidas "The Kobe 1" sneakers worn during Game 5 of the 2001 NBA Finals, photo-matched to the Los Angeles Lakers' championship-clinching victory over the Philadelphia 76ers.

A portion of the proceeds from the sale will be donated to the Lakers Youth Foundation, creating an opportunity for collectors to participate in preserving basketball history while supporting youth-focused community initiatives.

The auction is scheduled to open soon through Infinite Auctions. Collectors and fans may preview the offering and register for bidding notifications by visiting:

https://infiniteauctions.com/lots/6a2c62203fe056485b32cff9

Bidding will begin at $10,000, with an optional Buy-It-Now price of $240,000 available to qualified buyers.

The sneakers originate from June 15, 2001, when Bryant helped lead the Lakers to a decisive Game 5 victory, securing the franchise's second consecutive NBA Championship. The 2000-01 Lakers remain one of the most dominant playoff teams in league history, finishing the postseason with an extraordinary 15-1 record.

What makes this offering especially significant is the convergence of several elite collecting attributes rarely found in a single artifact:

Worn during a championship-clinching NBA Finals victory
Photo-matched to Game 5 of the 2001 NBA Finals
Dual signed by Kobe Bryant
Original Adidas "The Kobe 1" signature model
Directly connected to one of the most dominant championship runs in NBA history
Accompanied by professional authentication and photo-match documentation

"This is the type of artifact collectors wait years to see enter the market," said Marshall Perkins, CEO of Infinite Auctions. "Championship photo-matched Kobe Bryant memorabilia represents the highest tier of basketball collecting. When you add the historical significance of a Finals-clinching game and the charitable impact through the Lakers Youth Foundation, it becomes much more than a collectible."

Media Contact

Marshall Perkins
CEO, Infinite Auctions
530 E Hunt Highway, Suite 103-225
San Tan Valley, Arizona 85143
Phone: (480) 286-6678
Email: info@infiniteauctions.com
Website: www.InfiniteAuctions.com

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1177156

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

通过亲近自然来平复心境。我冲好咖啡，收拾好装备，前往码头。登上等待在那里的 Wave Chaser 时，我感受到了熟悉的期待感。今天是一个充满无限可能的新开始。 pic.twitter.com/3G2v6YvuYh— Marshall Perkins III (@MPerkinsIII) June 12, 2026

Marshall, since you scan this board, can you explain this post? I truly don't get it.

How are the auctions fake?

What’s your basis?

~~~~~~~~~~~~~
~~~~~~~~~~~~~









~~~~~~~~~~~~~


and lol to easymonee

—- “Wonder when [he] is going to release some of those cheap shares.”

.

Current environment he may not, but he has in the past.


GLTAL

Marshall won’t answer that. 

See if he addresses your question.

His past statements have been no R/S as it hurts long term shareholders and kills liquidity. IMO liquidity is why he canceled his 2 bil restricted shares and replaced them with Reg A fully tradable shares. Wonder when Kaplan is going to release some of those cheap shares.



GLTAL

Good afternoon.

Could/would you declare publicly (non safe harbour disclosure protected) that an R/S is not in the future for MDCE🤔

It appears that there is a lot of “funky” Pinkyland machinations going on.

Enjoy your weekend.

Be well

Because the auctions are fake

Medical Care Technologies (OTC PINK:MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform

Company initiates structured internal testing focused on platform stability, workflow optimization, and image consistency evaluation

MESA, AZ / ACCESS Newswire / June 12, 2026 / Medical Care Technologies, Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology company focused on artificial intelligence, imaging technologies, and digital wellness platforms, today announced the commencement of internal beta testing for its MDCE Melanoma Scan Beta platform.

The testing phase is designed to evaluate platform stability, workflow performance, image management functionality, interface responsiveness, and image consistency processes as the Company continues development of its AI-assisted imaging platform.

The MDCE Melanoma Scan Beta platform is being developed as an image organization and monitoring system intended to support longitudinal image management workflows. Internal testing will focus on identifying opportunities for refinement, validating core platform functions, and optimizing the overall user experience.

"Beginning structured internal testing represents an important milestone in our development process," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "Our focus is on building a stable, scalable, and well-engineered imaging platform through disciplined testing and continuous refinement."

The Company views the platform as part of its broader strategy involving AI-assisted imaging technologies, software infrastructure, and future digital wellness applications.

Medical Care Technologies emphasized that the MDCE Melanoma Scan Beta platform remains in beta-stage development. The pre-screening platform is not intended to treat, cure, or prevent any disease or medical condition and has not been reviewed or cleared by the U.S. Food and Drug Administration.

The Company expects to provide additional updates regarding testing milestones, platform enhancements, and future development initiatives as progress continues.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC PINK:MDCE) is a technology company focused on artificial intelligence, imaging technologies, digital wellness platforms, authentication technologies, and consumer software innovation. The Company is actively developing technology initiatives involving AI-assisted imaging, computer vision, and scalable software platforms.

Contact Information

Medical Care Technologies, Inc.
Website: https://medicalcaretechnologies.com/
Email: info@medicalcaretechnologies.com
Phone: 1-480-645-0750
Address: 1910 S Stapley Drive, Suite 221, Mesa, AZ 85204

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties. These statements include, but are not limited to, expectations regarding product development, testing activities, technology initiatives, future enhancements, and business strategy. Actual results may differ materially from those projected. Medical Care Technologies undertakes no obligation to update forward-looking statements except as required by law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1176464

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

If they are so successful in these auctions, why do the REG A at all?? Just cancel it and reduce the AS immediately. I just don’t think he knows how to do the administrative fillings. 

Dec.’s a good point, yet a ways off.
Thinking the .0002s don’t really have incentive to sell at .0001 as MDCE retail can’t go lower, and any 1s buyers will want out at least at 2s, so why would 2s sell to meet the bid at 0.0001 when they are just as likely to sell even, at minimum. The 1s may be willing to move to buy at 2. The MarketMakers, they have plenty on the ask and bid, and will meet the difference at 0.00015s too.

Marshall should just make the Reg A open to everyone and as many buyers as he can at his 0.0013 that he’s proposed.

That’s much smarter than selling the entire Reg-A to one person… and for the second time… which would in fact be giving away the company on the super cheap to one person.

.

There’s a reason why this is at the bottom. But Marshall will call you delusional and tell you to sell (into his bid)

Where’d all-those-shares come from if Kaplan didn’t sell?

Where’d the MarketMakers get all those shares to put up if Kaplan did not sell his shares?

20m on ask. 600m on bid. That 600m can happen with any type of bad news. Or in Dec when people cut their losses. Stand by 

Oh boy T1 and 2s stacking… no bid soon enough. Flush it 🚽

I have dry powder to buy the .0001's if they hit thru the summer. Stack those .0002's. LOL

Revenues going up and expenses going down, I like it.

GLTAL.

Looks like .0002’s are now stacking. Won’t be long before .0001’s start going. 

MDCE's Infinite Auctions Introduces New Auction Platform Combining Straight Bidding with Real-Time Buy It Now Functionality
ACCESS NEWSWIRE 6:30 AM ET 6/8/2026
Symbol Last Price Change
MDCE 0.0003 0 (0%)
QUOTES AS OF 12:00:00 AM ET 06/04/2026
Company unveils a modern auction experience that eliminates proxy bidding while introducing live Buy It Now functionality during premium sports memorabilia auctions.

MESA, AZ / ACCESS Newswire / June 8, 2026 / Medical Care Technologies Inc. (MDCE) today announced the launch of a redesigned Infinite Auctions next generation auction platform (https://infiniteauctions.com) as the company prepares to compete for increased market share in the multi-billion dollar sports collectibles market. The upcoming NBA Game Used Flash Auction 2026 is scheduled to begin June 27, 2026 and conclude July 18, 2026.


The updated disruptive platform introduces a straight-bid auction format that eliminates traditional proxy and maximum bidding systems commonly utilized throughout the auction industry. In addition, the platform features a live Buy It Now capability, allowing qualified buyers to immediately purchase select items during the auction process.

Management believes the updated approach offers a differentiated auction experience while providing collectors with greater transparency and flexibility during the bidding process.

The NBA Game Used Flash Auction 2026 is currently in preview mode, with new consignments being added daily leading up to the June 27 launch date.

Featured headline items currently include:


Kobe Bryant April 25, 2009 Game Worn & Dual Signed Playoff Sneakers vs. Utah Jazz (Western Conference Quarterfinals Game 4) with Real Game Used Photo Match Letter of Authenticity.


Allen Iverson February 27, 2006 Game Used Photo Matched Signed Philadelphia 76ers Road Jersey accompanied by MeiGray and Real Game Used Letters of Authenticity. Management believes this to be the only known photo matched jersey in this particular style and colorway.


LeBron James April 12, 2014 Game Used Photo Matched Miami Heat Away Jersey accompanied by NBA and MeiGray authentication. The jersey originates from James' record-setting tenth completed season averaging at least 25 points, 5 rebounds, and 5 assists, surpassing the previous mark established by Oscar Robertson.

The redesigned platform also highlights more than $3 million in historical sales and showcases numerous player collections featuring NBA Hall of Famers and some of basketball's most recognizable athletes.

In addition to consigned inventory, the company intends to utilize the auction as part of its broader initiative to liquidate an additional $50,000 to $150,000 of company-owned collectible assets to support operations and strategic initiatives across the Medical Care Technologies(MDCE) ecosystem.

"Launching our redesigned auction platform marks an important milestone for Infinite Auctions," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies(MDCE). "We believe the new format provides collectors with a unique and engaging auction experience while continuing our efforts to build value across the MDCE family of businesses."

The NBA Game Used Flash Auction 2026 preview can be viewed at InfiniteAuctions.com.

About Infinite Auctions

Founded in 2016, Infinite Auctions specializes in authenticated game-used sports memorabilia, athlete collections, and investment-grade collectibles. The company continues to expand its marketplace through technology development, authentication initiatives, and strategic industry relationships.

About Medical Care Technologies Inc.(MDCE)

Medical Care Technologies Inc. (MDCE) develops and operates technology-focused businesses spanning healthcare applications, artificial intelligence initiatives, memorabilia authentication technologies, consumer software platforms, and digital marketplaces.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws. Such statements include, but are not limited to, statements regarding future auction performance, anticipated asset sales, business strategies, platform adoption, future operational objectives, and other matters that are not historical facts. Actual results may differ materially from those anticipated due to various risks and uncertainties. Investors should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update forward-looking statements except as required by applicable law.

Company Contact:

Marshall Perkins
Chief Executive Officer
Infinite Auctions
530 E Hunt Hwy Suite 103-225
San Tan Valley, AZ 85143
480-988-5847
info@infiniteauctions.com

SOURCE: Medical Care Technologies Inc. (MDCE)



View the original press release on ACCESS Newswire

Agree, looks good. Nice looking site. Real nice.



~~~~~~~~~ ~~~~~~~~ ~~~~~~~~~

I too have “been seen alongside influential figures such as Logan Paul, Kevin O'Leary, and Shaquille O'Neal.” Some might call it my “expansive network and industry reach.”

Shaq at the club, and courtside.

O’Leary, front of the casino.

Paul, ringside.

Yes, very professional.

Auction items being added. Will be interesting to see the value, will it be a 200k or 500K+ auction.

I like the fact he is still mentioning key individuals on the new website....... Our CEO, Marshall Perkins III, has been seen alongside influential figures such as Logan Paul, Kevin O'Leary, and Shaquille O'Neal, underscoring Infinite Auctions' expansive network and industry reach.

I like the new Auction website.

https://infiniteauctions.com/

From the PR;

Safe harbour protected self fellating, share dumping reality protected bullshit

”The Company stated”

While the current platform remains in beta-stage development, Medical Care Technologies “views” the project as part of a broader effort to explore how artificial intelligence “may be” utilized to support future wellness-oriented imaging applications.


Medical Care Technologies “believes” advancements in artificial intelligence,

"Our vision” extends beyond a single application," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies.

”The Company noted” that ongoing development activities are helping establish internal expertise and technical infrastructure related to imaging

”Medical Care Technologies further stated that it believes” imaging technologies may represent an important long-term category within preventative wellness, consumer health applications, and future digital monitoring platforms.

"Our objective” is to build a technology foundation that supports innovation across multiple future opportunities," added Perkins.

”Medical Care Technologies expects”

The MDCE Melanoma Scan Beta platform remains in beta-stage development and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The platform has not been reviewed or cleared by the U.S. Food and Drug Administration.


🙈🙈—GLTA

Zero volume. Marshall keeps PRing the exact same thing.

His one man “long term” vision operation.

Selling near the entire company to one man, to raise relatively small cash, at can’t-go-lower rock bottom shares prices, tanking existing and “long term” shareholders in so doing.

Previously stated “long term” plan was to take care of existing shareholders.

Current plan is AI growth development by raising cash selling an additional 4.6 Billion shares at Rick bottom prices.

Yep, kind of crazy. I would rather see him concentrate on auction sales and building AI vision infrastructure. He has been talking a lot about Scale and infrastructure. We have recently sold 250k worth of assets, maybe we will be hearing about the purchase of infrastructure.



GLTAL

Nice when our CEO is a trader too 

That would be a 50% profit, can't blame traders for thinking it is not going anywhere. If you can get .0001's that's a 200% gain. There is a reason traders like trips when moving.
I added .0002's yesterday.


GLTAL

Buy at .0002 and put on ask at .0003. Is Marshall still trading this??

Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform

Company outlines long-term strategy surrounding AI-assisted imaging technologies and pre-screening wellness applications

MESA, AZ / ACCESS Newswire / June 4, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company"), a technology company focused on AI-powered consumer applications and imaging technologies, today provided additional insight into the long-term strategic vision supporting the development of its MDCE Melanoma Scan Beta platform and broader AI imaging initiatives.

The Company stated that the MDCE Melanoma Scan Beta platform represents an important component of a larger technology strategy centered on AI-assisted imaging, image management systems, and future image analysis infrastructure. While the current platform remains in beta-stage development, Medical Care Technologies views the project as part of a broader effort to explore how artificial intelligence may be utilized to support future wellness-oriented imaging applications.

Medical Care Technologies believes advancements in artificial intelligence, computer vision technologies, image processing systems, and scalable software infrastructure are creating new opportunities for the development of intelligent imaging platforms capable of supporting a wide range of future use cases.

"Our vision extends beyond a single application," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "We are evaluating how AI-assisted imaging technologies, image analysis frameworks, and scalable software infrastructure may be applied across multiple future technology initiatives. The MDCE Melanoma Scan Beta platform serves as an important foundation within that broader strategy."

The Company noted that ongoing development activities are helping establish internal expertise and technical infrastructure related to imaging workflows, image management systems, software architecture, and future AI-assisted analytical capabilities.

Medical Care Technologies further stated that it believes imaging technologies may represent an important long-term category within preventative wellness, consumer health applications, and future digital monitoring platforms. As a result, the Company intends to continue evaluating opportunities involving AI-assisted imaging systems and related technology initiatives as part of its broader innovation strategy.

The Company emphasized that its current efforts remain focused on development, testing, refinement, and evaluation activities associated with the MDCE Melanoma Scan Beta platform. Future technology initiatives, expansion opportunities, and potential applications remain subject to ongoing research, development progress, resource availability, regulatory considerations, and market conditions.

"Our objective is to build a technology foundation that supports innovation across multiple future opportunities," added Perkins. "We believe the convergence of artificial intelligence, imaging technologies, and scalable software platforms may create meaningful opportunities for continued development and exploration."

Medical Care Technologies expects to continue providing shareholders with updates regarding platform development activities, AI imaging initiatives, testing programs, infrastructure expansion efforts, and broader technology strategy milestones as they occur.

The MDCE Melanoma Scan Beta platform remains in beta-stage development and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The platform has not been reviewed or cleared by the U.S. Food and Drug Administration.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. is a technology company focused on AI-powered consumer applications, imaging technologies, wellness platforms, authentication technologies, and digital innovation initiatives. The Company continues to evaluate opportunities involving artificial intelligence, imaging systems, software development, and emerging technology applications.

Investor / Media Contact:
Medical Care Technologies Inc.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
+1 480-645-0750
info@medicalcaretechnologies.com

X: https://x.com/medicalcaretech
Website: https://medicalcaretechnologies.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include, but are not limited to, statements regarding future development initiatives, AI imaging technologies, technology strategy, testing plans, commercialization opportunities, platform expansion efforts, and future growth objectives. The Company undertakes no obligation to publicly update forward-looking statements except as required by applicable law.

SOURCE: Medical Care Technologies Inc.


View the original press release on ACCESS Newswire

https://app.accessnewswire.com/img.ashx?id=1172115

© Copyright 2026 ACCESS Newswire. All Rights Reserved.

WOW... 5m .0001's were sold/bought today. Is this going to break the seal or a one time thing??

three months later and not 1 single share added to the unrestricted (a few restricted added):

Outstanding Shares 3,542,275,230 05/29/2026
Restricted 570,000,395 05/29/2026
Unrestricted 2,972,274,835 05/29/2026

Outstanding Shares 3,392,275,230 03/23/2026
Restricted 420,000,395 03/23/2026
Unrestricted 2,972,274,835 03/23/2026

If the shoe fits—Wear it proudly.

Not “a good sign” of what?

DISTURBING FACTS🤔

Marshall has you on a string.

Good luck to you.

Wow, and you were doing so well. Getting personal with board participants is not a good look.

Vol. is pickup up, always a good sign.


GLTAL

.0001’s hit😱😱— Whoomp there it is exactly as expected and called 🙈🙈

https://investorshub.advfn.com/stock-market/USOTC/medical-care-technologies-id-MDCE/trades



0001 BID HITS HAVE ARRIVED TO YOUR SCREENS 🙈

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177633312

Respectfully;

You’re a classic Pinkyland hopium laden CEO manipulated BS disseminating stuckholder.

You’re a puppet on a string (JMO).



GL!

MDCE🤔

Buyers be aware;

It is what it is and always will be🙈

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177560769

Bottomless.0002’s available for all and a quick reality masking effort .0003 paint exactly as called long ago🤫

https://investorshub.advfn.com/stock-market/USOTC/medical-care-technologies-id-MDCE/trades

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177610573

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177666132

Black and white facts matter!!

Positive Pollys are out. I get it, you’re massaging your investment.

* Filing also says 1.1M of Kaplan shares were sold (in Q3 2025).
* Marshall’s post said 2B sold in Q1 2026.
* Form-1 stating 1,970,195,087 outstanding shares is only an “lol” and laughable?, when OTC Markets and Q1 says current outstanding is 3,250,167,248 MDCE shares. No filed correction a month and a half later.
* Huge Reg-A #2 pending dilution, up to and likely 4.6 Billion shares, as planned.
* You claim “there is a plan for those shares” and that “they just have not chosen to tell us what it is” regarding MedCareTechInc.’s management and direction of the company per the Kaplan’s shares. Really? What do you know that you don’t know? LOL! Seems the actual plan is for Kaplan to flip those shares… again. Maybe there’s a ‘plan’ newly getting adjusted now.
* There’s no plan, but for both to raise cash.
* Marshall has conveyed nothing about it.
* Marshall leaves important questions unanswered even after when posed directly to him.

Chart is bullish? Really? Please do tell how.

I appreciate your support and positive outlook.
However, you’re sure heavy on the colorful sprinkles, to the point of so-happy put-a-smile-on-it pollyanna-ish positivity. There seems appearance to choose to readily ignore the multiple and significant irregularities that are left unaddressed by MedCareTechInc mngt day after day. It’s called massaging your investment.

I want to like Marshall. Yet seems he’s dug a hole that he and Kaplan’s plan is ‘hope it goes away.’ And although he is doing something and has some real revenues, and he may deliver a solid legitimate product, he’s also showing to be yet another OTC company. I had hoped he’d keep the ball in the court.

.

I asked him on X if he has a timeline on the release of test data on the Melanoma platform. I like the word platform, sounds more substantial than phone app. I understand the word platform, as I had a hand in developing one years ago that is still in use. Glad Marshall is using terms that make sense to long term programmers/IT folks and KNOW what it takes.


GLTAL

Chart has become bullish over the last week. Some have been loading .0002's for the last 30 days. Appears not many .0002's left.

Marshall has been addressing SH questions thru PR's and X posts.

GLTAL

Trend is for days to get slightly bigger hits of the ask :) 4M bought off the ooo3s just now

Yep the Kaplan shares. There is a plan for all those shares, as of last filing none of the shares have been sold. Just bought and held.

There is a plan, they just have not chosen to tell us what it is.

Many have speculated it is just a pump and dump for the last 8-10 months.

The Reg A filing showing only 1.9 B shares OS is also very interesting. Marshall still working on it....LOL

GLTAL

Seems there’s the big elephant. Those Kaplan shares.

So many. So many more planned to come. And, hhmmm. who owns them?

I showed you and others the elephant. Several times too.

You can’t afford to consider?

.noticeable.

I guess there is nothing else to discuss.

We both agree Marshall has to come thru. Will he, I am betting as are others he has something coming.

We have all waited for years, what's a few more weeks to months to fulfill the plan. Or just sell and move on.


GLTAL

Not sure I’d say chart is bullish. it’s sitting bottom like it has for many months/years.  Marshall clearly has not shown an interest in price action or liquidity. Yes, I know he is busy building the company as he has stated for 4+ years but price is a part of that as well. another piece as to the lack of interest thus far.

I concur. The ball is in Marshalls court, as it always has been. Will he come thru with the things you suggest, and even more.

Some are not sure, others are adding the .0002's.0003's as that is currently the bottom.

When in doubt trust the chart, it is currently bullish.


GLTAL